Abraxane (Albumin-bound Paclitaxel for Injectable Suspension) Drug Information: Description, User Reviews, Drug Side Effects....Interactions - Prescribing Information at RxList Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, August 19, 2015

Abraxane (Albumin-bound Paclitaxel for Injectable Suspension) Drug Information: Description, User Reviews, Drug Side Effects....Interactions - Prescribing Information at RxList



RxList


WARNING
NEUTROPENIA
Do not administer ABRAXANE therapy to patients who have baseline neutrophil counts of less than 1,500 cells/mm³. In order to monitor the occurrence of bone marrow suppression, primarily neutropenia, which may be severe and result in infection, it is recommended that frequent peripheral blood cell counts be performed on all patients receiving ABRAXANE [see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS].

Note: An albumin form of paclitaxel may substantially affect a drug's functional properties relative to those of drug in solution. DO NOT SUBSTITUTE FOR OR WITH OTHER PACLITAXEL FORMULATIONS.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.